Histiocytoid cardiomyopathy: a mitochondrial disorder
Related Experiment Video
Updated: Jul 5, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
1Neurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria. duarte@aonmail.at
Insights
Histiocytoid cardiomyopathy (HICMP) is a rare genetic heart disorder in children, often causing arrhythmias or dilated cardiomyopathy. This condition is characterized by abnormal heart cells and is considered a mitochondrial cardiomyopathy due to its association with mitochondrial DNA mutations.
Area of Science:
- Cardiology
- Genetics
- Mitochondrial Biology
Background:
- Histiocytoid cardiomyopathy (HICMP) is a rare genetic cardiac disorder affecting infants and children, predominantly girls.
- Clinically, it manifests as severe cardiac arrhythmias or dilated cardiomyopathy.
- Pathoanatomically, it features characteristic nodules composed of abnormal Purkinje fibers and histiocytoid myocytes.
Purpose of the Study:
- To elucidate the pathological characteristics of Histiocytoid Cardiomyopathy.
- To investigate the cellular and subcellular basis of HICMP.
- To establish the classification of HICMP as a mitochondrial cardiomyopathy.
Main Methods:
- Histopathological examination of cardiac tissue.
- Analysis of cardiomyocyte morphology and mitochondrial content.
- Assessment of mitochondrial enzyme activity (succinate-cytochrome c reductase, NADH-cytochrome c reductase).
- Correlation with mitochondrial DNA (mtDNA) mutation status.
Main Results:
- HICMP is characterized by subendocardial, epicardial, or valvular nodules containing abnormal Purkinje fibers and histiocytoid myocytes.
- These myocytes are filled with an increased number of normal or abnormal mitochondria.
- Yellowish areas in the myocardium consist of enlarged, histiocyte-like cells with foamy cytoplasm.
- A frequent association with mitochondrial DNA mutations was observed.
Conclusions:
- HICMP cardiomyocytes exhibit an increased number of mitochondria, some abnormal.
- Markedly decreased mitochondrial enzyme activity (succinate-cytochrome c reductase, NADH-cytochrome c reductase) is observed.
- HICMP should be classified as a mitochondrial cardiomyopathy due to its pathological and genetic links to mitochondrial dysfunction.
Abstract:
Histiocytoid cardiomyopathy (HICMP) is a rare, genetic, cardiac disorder of infancy or childhood, predominantly affecting girls, and clinically manifesting as severe cardiac arrhythmias or dilated cardiomyopathy. Pathoanatomically, HICMP is characterized by subendocardial, epicardial, or valvular yellow-tan nodules, which are histologically built up of abnormal Purkinje fibers and multiple, scattered clusters of histiocytoid myocytes, which are filled with an increased number of normal or abnormal mitochondria. Within the myocardium, yellowish areas with irregular outlines are found and are histologically built up of enlarged, polygonal, histiocyte-like cells with foamy granular cytoplasm. Since HICMP is frequently found in patients with mitochondrial deoxyribonucleic acid (DNA) mutations, HICMP cardiomyocytes carry an increased number of normal or abnormal mitochondria, and may show markedly decreased succinate-cytochrome c reductase or NADH-cytochrome c reductase activity; HICMP should be regarded as mitochondrial cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
The Inner Mitochondrial Membrane
Cardiomyopathy IV: Restrictive Cardiomyopathy
Animal Mitochondrial Genetics
Mitochondrial Membranes

